drugset

drugset / Trial / NCT00448396

Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

NCT00448396 ↗

Phase 1 Completed 17 enrolled Novartis Pharmaceuticals

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the effects of patupilone on the pharmacokinetics of warfarin in patients with advanced malignancies.

Timeline

Start: 2007-03
Primary completion: 2008-02
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Patupilone	Small molecule	—	—

Indications